Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teladoc Health, Inc. – TDOC
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at...
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
GlobeNewswire, Inc.
TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced a new exclusive distribution agreement with Peak Medical, a complete medical...
Nanox and Vertec Scientific Enter Exclusive Sales Reseller Agreement for the Commercialization of Nanox.AI Bone Solution (HealthOST) in the United Kingdom
GlobeNewswire, Inc.
Initial three-year term includes minimum annual license commitments PETACH TIKVA, ISRAEL, August 18 2026 -- Nanox Imaging Ltd. (“Nanox”, or the “Company” NASDAQ: NNOX), a leader in innovative medical imaging technology, today announced its...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
Nasus Pharma Reports First Half 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Appointed Pharma Industry Veteran Brendan O’Grady as Chief Executive Officer Company on Track to Advance Clinical Programs to Key Second Half 2026 Milestones TEL AVIV, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX)...
ENvue Medical Moves NanoVibronix Manufacturing to the United States, Consolidates R&D in Tel Aviv, Israel, Increasing Operational Efficiencies and Cost Reduction Opportunities
GlobeNewswire, Inc.
TYLER, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (“ENvue” or the “Company”), a commercial-stage medical device company, today announced it has completed the transition of its NanoVibronix manufacturing operations...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewswire, Inc.
NEW YORK, Aug. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
Wearable Healthcare Devices Market to Grow from USD 45.29 Billion in 2025 to USD 75.98 Billion by 2030, at a CAGR of 10.9% – MarketsandMarkets™
GlobeNewswire, Inc.
Delray Beach, FL, Aug. 14, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global wearable healthcare devices market will grow from USD 45.29 billion in 2025 to USD 75.98 billion by 2030, at a CAGR of 10.9% during the forecast period....
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Successful initiation of the Phase 2/3 clinical trial of SIL204 at Tel Aviv Sourasky Medical Center (“TASMC” or “Ichilov”), one of Israel’s largest and most prominent academic medical centers, clears the site to commence patient screening...
ENvue Medical Secures Equity Financing Facility of Up to $50 Million to Support Commercial Growth, Technology Expansion and Strategic Acquisitions
GlobeNewswire, Inc.
TYLER, Texas, Aug. 12, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) ("ENvue" or the "Company"), a commercial-stage medical technology company, today announced that it has entered into a securities purchase agreement (“ELOC”) with an...
Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot
GlobeNewswire, Inc.
NESS ZIONA, Israel, Aug. 12, 2026 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd. (“Mapi” or the “Company”), a late-stage clinical biopharmaceutical company specializing in long-acting injectable therapies, today announced initial clinical results from its...
Skn Elements Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
MIAMI, FL, UNITED STATES, August 12, 2026 /EINPresswire.com/ -- Skn Elements is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
Israel and the occupied territories: ICRC facilitates voluntary return of 88 individuals to Gaza
International Committee of the Red Cross
At the request and with the agreement of relevant authorities, the ICRC transferred the individuals from Kerem Shalom crossing to Nasser Medical Complex in Gaza. Our team also facilitated their communication with families as needed.
Dallas LuxLift Introduces the Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
FRISCO, TX, UNITED STATES, August 12, 2026 /EINPresswire.com/ -- Dallas LuxLift is proud to announce the addition of the Candela Matrix® platform to its comprehensive suite of aesthetic services.
IIA Survey Reports Israeli High-Tech at Turning Point as Software Companies Downsize and Hardware Companies Expand
EIN Presswire
Despite layoffs, Israeli high-tech employment remains stable, divide emerges between software and hardware, and AI is beginning to reshape hiring and workforce JERUSALEM, ISRAEL, August 11, 2026 /EINPresswire.com/ -- A new survey conducted by...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ARS Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – SPRY
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against ARS Pharmaceuticals, Inc. (“ARS” or the “Company”) (NASDAQ: SPRY). Such investors are advised to contact Danielle Peyton at...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC
GlobeNewswire, Inc.
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC). Such investors are advised to contact Danielle Peyton at...
Sign up for:
Israel Healthcare News
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.